# Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Injection
> **Food and Drug Administration** · Final rule. · Published 1999-05-17 · Effective 1999-05-17 · 64 FR 26670
## Document
- **Document number:** 99-12284
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 64 FR 26670
- **CFR reference:** 21 CFR 522
- **Publication date:** 1999-05-17
- **Effective date:** 1999-05-17
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Boehringer Ingelheim Vetmedica, Inc. The supplemental ANADA provides for establishment of a 28-day withdrawal period for subcutaneous use of oxytetracycline injection in cattle and for intramuscular use in swine.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1999/05/17/99-12284/implantation-or-injectable-dosage-form-new-animal-drugs-oxytetracycline-injection)
---
*AI Analytics · CC0 1.0*